Choose from the following list of conference sessions:
Genetic Basis and Pathogenesis
Defining Waldenstrom's Macroglobulinemia
Prognostic Markers Waldenstrom's Macroglobulinemia
Therapeutics in WM: Alkylator agents and nucleoside analogues
Therapeutics in WM: Monoclonal Antibodies
Therapeutics in WM: Thalidomide
Therapeutics in WM: Transplant Therapy
Click on the following links to display the corresponding IWWM-2 Consensus Panel report:
Consensus Panel One: Clinicopathological Definition of WM
Consensus Panel Two: Prognostic Markers and Citeria to Treat WM